JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JCM Accepts, published online ahead of print on 14 May 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.00177-08v1
46/7/2212    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Lounis, N.
Right arrow Articles by Andries, K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lounis, N.
Right arrow Articles by Andries, K.

 Previous Article  |  Next Article 

J. Clin. Microbiol. doi:10.1128/JCM.00177-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Prevention of Drug Carry-Over Effects in Studies Assessing the Antimycobacterial Efficacy of TMC207

Nacer Lounis*, Tom Gevers, Joke Van Den Berg, Tom Verhaeghe, Rolf van Heeswijk, and Koen Andries

Tibotec Pharmaceuticals Ltd., Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium; and Pharmaceutical Research and Development, Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium

* To whom correspondence should be addressed. Email: nlounis{at}tibbe.jnj.com.


   Abstract

The levels of TMC207 (R207910) that can be reached in mouse organs and sputa of treated patients easily exceed the MIC of the compound, and can therefore interfere with in vitro bacterial titrations. We studied the usefullness of protein-enriched media to prevent such drug carry-over effects. The average MIC of Mycobacterium tuberculosis was determined on 3 different media: unsupplemented 7H11 agar (MIC = 0.03 microgram/ml), 7H11 agar supplemented with 5% BSA (MIC = 1 microgram/ml) and Lowenstein Jensen (MIC = 14.33 microgram/ml). In a second stage, the maximal non inhibitory concentrations (MNIC) of TMC207 were determined by adding TMC207 to the bacterial inoculum rather than to the culture medium. These MNIC values were 0.97 µg/ml for 7H11 agar, 32.33 µg/ml for 7H11 agar with 5% BSA, and 96.33 µg/ml for Lowenstein Jensen medium. Both protein-enriched media were able to prevent drug carry-over effects, but the use of 7H11 medium supplemented with 5% BSA is preferred for practical reasons.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.